Researchers have developed a new genomic method, named CUTseq, which can assess the amount and type of CNAs in many different parts of the same tumor, at a much lower cost than existing technologies
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.